Applications

1683 – MRI of the liver, for the evaluation of hepatic metastases for initial staging or restaging prior to treatment using interventional techniques

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type Referral
  • Pre-PASC consultation Not applicable
  • Pre-MSAC consultation Closed
  • Outcome Supported

Application details

Reason for application

The Diagnostic Imaging Clinical Committee of the MBS Review Taskforce recommended a new MBS item for MRI of the liver for the evaluation of hepatic metastases for initial staging or restaging prior to treatment using interventional techniques.

MSAC application 1372.1 was for MRI of the liver for patients with known colorectal carcinoma (CRC) with suspected or proven liver metastases and patients with known or suspected hepatocellular carcinoma (HCC) for the purposes of cancer staging. However, this service is limited to patients with known CRC with suspected or proven liver metastases and patients with known or suspected HCC. A service is required for MRI of the liver for additional oncologic indications.

Service or technology in this application

Magnetic Resonance Imaging (MRI) to image the liver. MRI utilises strong, uniform magnetic fields to investigate the anatomy, perfusion, tissue characterisation and function of different organs and systems within the human body.

Type: Investigative technology

Medical condition this application addresses

MRI of the liver for the evaluation of hepatic metastases for initial staging or restaging prior to treatment using interventional techniques.

Application documents

Public summary document

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Consultation survey and deadlines

  • PASC consultation: Not applicable
  • MSAC consultation: Closed 8 October 2021

Meetings to consider this application

  • PASC meeting: Bypassed PASC
  • ESC meeting: Bypassed ESC
  • MSAC meeting: 25–26 November 2021